The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
Angiotensin receptor blockers (ARBs) are with increasing frequency used in arterial hypertension treatment, this class of medications is especially important in treatment of patients with obesity, metabolic syndrome and diabetes mellitus. Although not all the ARBs are the therapy of first choice in...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2019-09-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/viewFile/33549/pdf |